Volume 15, Number 8—August 2009
Increase in Pneumococcus Macrolide Resistance, United States
|US region†|| Isolates, no. resistant/no. submitted (%)
|Year 5||Year 6|
|Northeast||518/1,931 (26.8)||662/2,102 (31.5)|
|North Central||467/1,314 (35.5)||568/1,395 (40.7)|
|Northwest||94/417 (22.5)||108/422 (25.6)|
|Southeast||340/998 (34.1)||419/1,064 (39.4)|
|South Central||402/1,149 (35.0)||529/1,368 (38.7)|
|Southwest||86/448 (19.2)||95/396 (24.0)|
|Total||1,907/6,257 (30.5)||2,381/6,747 (35.3)|
*PROTEKT US, Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin, United States.
†States submitting isolates for testing included Northeast: CT, DE, IN, MA, MD, MI, NJ, NY, OH, PA, RI, VT, and DC; North Central: IA, IL, KS, MN, MD, ND, NE, SD, and WI; Northwest: AK, ID, MT, OR, WA, and WY; Southeast: FL, GA, KY, NC, SC, VA, and WV; South Central: AL, AR, LA, OK, TN, and TX; Southwest: AZ, CA, CO, NM, NV, and UT.